ID   PYGB_HUMAN              Reviewed;         843 AA.
AC   P11216; Q96AK1; Q9NPX8;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 5.
DT   10-MAY-2017, entry version 196.
DE   RecName: Full=Glycogen phosphorylase, brain form {ECO:0000303|PubMed:3346228};
DE            EC=2.4.1.1 {ECO:0000269|PubMed:27402852};
GN   Name=PYGB {ECO:0000303|PubMed:3346228};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=3346228;
RA   Newgard C.B., Littman D.R., van Genderen C., Smith M.,
RA   Fletterick R.J.;
RT   "Human brain glycogen phosphorylase. Cloning, sequence analysis,
RT   chromosomal mapping, tissue expression, and comparison with the human
RT   liver and muscle isozymes.";
RL   J. Biol. Chem. 263:3850-3857(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=2615594; DOI=10.1016/0169-328X(89)90052-1;
RA   Gelinas R.P., Froman B.E., McElroy F., Tait R.C., Gorin F.A.;
RT   "Human brain glycogen phosphorylase: characterization of fetal cDNA
RT   and genomic sequences.";
RL   Brain Res. Mol. Brain Res. 6:177-185(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-11.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-11; 18-30; 51-61; 71-78; 193-206; 271-278;
RP   353-359; 388-395; 400-425; 508-520; 522-533; 546-552; 558-569;
RP   577-590; 623-640; 657-681; 731-754 AND 817-823, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon adenocarcinoma;
RA   Bienvenut W.V., Murray L., Brunton V.G., Frame M.C.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1-843 IN COMPLEX WITH AMP,
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, SUBUNIT, AND
RP   PHOSPHORYLATION.
RX   PubMed=27402852; DOI=10.1074/jbc.M116.738898;
RA   Mathieu C., de la Sierra-Gallay I.L., Duval R., Xu X., Cocaign A.,
RA   Leger T., Woffendin G., Camadro J.M., Etchebest C., Haouz A.,
RA   Dupret J.M., Rodrigues-Lima F.;
RT   "Insights into Brain Glycogen Metabolism: THE STRUCTURE OF HUMAN BRAIN
RT   GLYCOGEN PHOSPHORYLASE.";
RL   J. Biol. Chem. 291:18072-18083(2016).
CC   -!- FUNCTION: Glycogen phosphorylase that regulates glycogen
CC       mobilization (PubMed:27402852). Phosphorylase is an important
CC       allosteric enzyme in carbohydrate metabolism (PubMed:3346228).
CC       Enzymes from different sources differ in their regulatory
CC       mechanisms and in their natural substrates (PubMed:3346228).
CC       However, all known phosphorylases share catalytic and structural
CC       properties (PubMed:3346228). {ECO:0000269|PubMed:27402852,
CC       ECO:0000303|PubMed:3346228}.
CC   -!- CATALYTIC ACTIVITY: ((1->4)-alpha-D-glucosyl)(n) + phosphate =
CC       ((1->4)-alpha-D-glucosyl)(n-1) + alpha-D-glucose 1-phosphate.
CC       {ECO:0000269|PubMed:27402852}.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- ENZYME REGULATION: Activity of phosphorylase is controlled both by
CC       allosteric means (through the non-covalent binding of metabolites)
CC       and by covalent modification. Thus AMP allosterically activates,
CC       whereas ATP, ADP, and glucose-6-phosphate allosterically inhibit,
CC       phosphorylase B. Activated upon phosphorylation.
CC       {ECO:0000269|PubMed:27402852}.
CC   -!- SUBUNIT: Homodimer. Dimers associate into a tetramer to form the
CC       enzymatically active phosphorylase A.
CC       {ECO:0000269|PubMed:27402852}.
CC   -!- INTERACTION:
CC       P06737:PYGL; NbExp=8; IntAct=EBI-1047231, EBI-2511865;
CC       Q8IUQ4:SIAH1; NbExp=3; IntAct=EBI-1047231, EBI-747107;
CC   -!- PTM: Phosphorylated (PubMed:27402852). Phosphorylation of Ser-15
CC       converts phosphorylase B (unphosphorylated) to phosphorylase A (By
CC       similarity). {ECO:0000250|UniProtKB:P11217,
CC       ECO:0000269|PubMed:27402852}.
CC   -!- SIMILARITY: Belongs to the glycogen phosphorylase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03544; AAA59597.1; -; mRNA.
DR   EMBL; U47025; AAB60395.1; -; mRNA.
DR   EMBL; AL121772; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017045; AAH17045.1; -; mRNA.
DR   EMBL; BC030795; AAH30795.1; -; mRNA.
DR   CCDS; CCDS13171.1; -.
DR   PIR; A40138; A40138.
DR   RefSeq; NP_002853.2; NM_002862.3.
DR   UniGene; Hs.368157; -.
DR   PDB; 5IKO; X-ray; 2.50 A; A=1-843.
DR   PDB; 5IKP; X-ray; 3.40 A; A=1-843.
DR   PDBsum; 5IKO; -.
DR   PDBsum; 5IKP; -.
DR   ProteinModelPortal; P11216; -.
DR   SMR; P11216; -.
DR   BioGrid; 111792; 50.
DR   IntAct; P11216; 7.
DR   STRING; 9606.ENSP00000216962; -.
DR   BindingDB; P11216; -.
DR   ChEMBL; CHEMBL3856; -.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   CAZy; GT35; Glycosyltransferase Family 35.
DR   iPTMnet; P11216; -.
DR   PhosphoSitePlus; P11216; -.
DR   SwissPalm; P11216; -.
DR   BioMuta; PYGB; -.
DR   DMDM; 20178317; -.
DR   EPD; P11216; -.
DR   MaxQB; P11216; -.
DR   PaxDb; P11216; -.
DR   PeptideAtlas; P11216; -.
DR   PRIDE; P11216; -.
DR   DNASU; 5834; -.
DR   Ensembl; ENST00000216962; ENSP00000216962; ENSG00000100994.
DR   GeneID; 5834; -.
DR   KEGG; hsa:5834; -.
DR   UCSC; uc002wup.4; human.
DR   CTD; 5834; -.
DR   DisGeNET; 5834; -.
DR   GeneCards; PYGB; -.
DR   HGNC; HGNC:9723; PYGB.
DR   HPA; HPA031067; -.
DR   MIM; 138550; gene.
DR   neXtProt; NX_P11216; -.
DR   OpenTargets; ENSG00000100994; -.
DR   PharmGKB; PA34066; -.
DR   eggNOG; KOG2099; Eukaryota.
DR   eggNOG; COG0058; LUCA.
DR   GeneTree; ENSGT00390000016886; -.
DR   HOVERGEN; HBG006848; -.
DR   InParanoid; P11216; -.
DR   KO; K00688; -.
DR   OMA; ATYEYYN; -.
DR   OrthoDB; EOG091G03RB; -.
DR   PhylomeDB; P11216; -.
DR   TreeFam; TF300309; -.
DR   BioCyc; MetaCyc:HS02178-MONOMER; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-70221; Glycogen breakdown (glycogenolysis).
DR   ChiTaRS; PYGB; human.
DR   GenomeRNAi; 5834; -.
DR   PRO; PR:P11216; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000100994; -.
DR   CleanEx; HS_PYGB; -.
DR   ExpressionAtlas; P11216; baseline and differential.
DR   Genevisible; P11216; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0008184; F:glycogen phosphorylase activity; IBA:GO_Central.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IBA:GO_Central.
DR   GO; GO:0005980; P:glycogen catabolic process; IBA:GO_Central.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   CDD; cd04300; GT1_Glycogen_Phosphorylase; 1.
DR   InterPro; IPR011833; Glycg_phsphrylas.
DR   InterPro; IPR000811; Glyco_trans_35.
DR   PANTHER; PTHR11468; PTHR11468; 1.
DR   Pfam; PF00343; Phosphorylase; 1.
DR   PIRSF; PIRSF000460; Pprylas_GlgP; 1.
DR   TIGRFAMs; TIGR02093; P_ylase; 1.
DR   PROSITE; PS00102; PHOSPHORYLASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; Carbohydrate metabolism;
KW   Complete proteome; Direct protein sequencing; Glycogen metabolism;
KW   Glycosyltransferase; Phosphoprotein; Polymorphism;
KW   Pyridoxal phosphate; Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|Ref.6}.
FT   CHAIN         2    843       Glycogen phosphorylase, brain form.
FT                                /FTId=PRO_0000188535.
FT   REGION      677    678       Pyridoxal 5'-phosphate.
FT                                {ECO:0000269|PubMed:27402852}.
FT   BINDING      43     43       AMP; shared with dimeric partner.
FT                                {ECO:0000269|PubMed:27402852}.
FT   BINDING     197    197       AMP. {ECO:0000269|PubMed:27402852}.
FT   BINDING     310    310       AMP. {ECO:0000269|PubMed:27402852}.
FT   BINDING     569    569       Pyridoxal 5'-phosphate.
FT                                {ECO:0000269|PubMed:27402852}.
FT   SITE         76     76       Participates in a stacking interaction
FT                                with the adenine ring of AMP.
FT                                {ECO:0000269|PubMed:27402852}.
FT   SITE        109    109       Involved in the association of subunits.
FT                                {ECO:0000250}.
FT   SITE        143    143       Involved in the association of subunits.
FT                                {ECO:0000250}.
FT   SITE        156    156       May be involved in allosteric control.
FT                                {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.6}.
FT   MOD_RES      15     15       Phosphoserine; by PHK; in form
FT                                phosphorylase A.
FT                                {ECO:0000250|UniProtKB:P11217}.
FT   MOD_RES     197    197       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q8CI94}.
FT   MOD_RES     473    473       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q8CI94}.
FT   MOD_RES     681    681       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000269|PubMed:27402852}.
FT   VARIANT     303    303       A -> S (in dbSNP:rs2228976).
FT                                /FTId=VAR_034428.
FT   VARIANT     502    502       D -> N (in dbSNP:rs2227891).
FT                                /FTId=VAR_020212.
FT   CONFLICT      2      3       AK -> GE (in Ref. 1 and 2).
FT                                {ECO:0000305}.
FT   CONFLICT    248    248       K -> R (in Ref. 1; AAA59597).
FT                                {ECO:0000305}.
FT   CONFLICT    302    302       A -> G (in Ref. 1; AAA59597).
FT                                {ECO:0000305}.
FT   CONFLICT    835    843       IPPPNIPRD -> LQHLPHPEWESGGATCWAPPELCTHLAM
FT                                Y (in Ref. 1; AAA59597). {ECO:0000305}.
FT   HELIX        23     38       {ECO:0000244|PDB:5IKO}.
FT   TURN         44     46       {ECO:0000244|PDB:5IKO}.
FT   HELIX        49     78       {ECO:0000244|PDB:5IKO}.
FT   STRAND       82     86       {ECO:0000244|PDB:5IKO}.
FT   HELIX        96    102       {ECO:0000244|PDB:5IKO}.
FT   HELIX       106    115       {ECO:0000244|PDB:5IKO}.
FT   HELIX       120    126       {ECO:0000244|PDB:5IKO}.
FT   STRAND      130    132       {ECO:0000244|PDB:5IKP}.
FT   HELIX       136    150       {ECO:0000244|PDB:5IKO}.
FT   STRAND      155    160       {ECO:0000244|PDB:5IKO}.
FT   STRAND      168    172       {ECO:0000244|PDB:5IKO}.
FT   STRAND      175    179       {ECO:0000244|PDB:5IKO}.
FT   TURN        183    186       {ECO:0000244|PDB:5IKO}.
FT   HELIX       195    197       {ECO:0000244|PDB:5IKO}.
FT   STRAND      199    210       {ECO:0000244|PDB:5IKO}.
FT   STRAND      213    232       {ECO:0000244|PDB:5IKO}.
FT   STRAND      234    237       {ECO:0000244|PDB:5IKP}.
FT   STRAND      239    248       {ECO:0000244|PDB:5IKO}.
FT   HELIX       260    274       {ECO:0000244|PDB:5IKO}.
FT   HELIX       275    277       {ECO:0000244|PDB:5IKO}.
FT   STRAND      279    281       {ECO:0000244|PDB:5IKO}.
FT   HELIX       290    313       {ECO:0000244|PDB:5IKO}.
FT   HELIX       326    329       {ECO:0000244|PDB:5IKO}.
FT   HELIX       330    333       {ECO:0000244|PDB:5IKO}.
FT   STRAND      334    341       {ECO:0000244|PDB:5IKO}.
FT   HELIX       342    345       {ECO:0000244|PDB:5IKO}.
FT   HELIX       346    356       {ECO:0000244|PDB:5IKO}.
FT   HELIX       362    372       {ECO:0000244|PDB:5IKO}.
FT   STRAND      373    376       {ECO:0000244|PDB:5IKO}.
FT   HELIX       382    384       {ECO:0000244|PDB:5IKO}.
FT   STRAND      387    389       {ECO:0000244|PDB:5IKO}.
FT   HELIX       390    396       {ECO:0000244|PDB:5IKO}.
FT   HELIX       398    418       {ECO:0000244|PDB:5IKO}.
FT   HELIX       423    429       {ECO:0000244|PDB:5IKO}.
FT   STRAND      431    433       {ECO:0000244|PDB:5IKO}.
FT   STRAND      435    437       {ECO:0000244|PDB:5IKO}.
FT   STRAND      439    441       {ECO:0000244|PDB:5IKO}.
FT   HELIX       442    448       {ECO:0000244|PDB:5IKO}.
FT   STRAND      453    457       {ECO:0000244|PDB:5IKO}.
FT   HELIX       458    466       {ECO:0000244|PDB:5IKO}.
FT   TURN        467    469       {ECO:0000244|PDB:5IKO}.
FT   HELIX       470    475       {ECO:0000244|PDB:5IKO}.
FT   HELIX       477    479       {ECO:0000244|PDB:5IKO}.
FT   STRAND      480    482       {ECO:0000244|PDB:5IKO}.
FT   HELIX       490    495       {ECO:0000244|PDB:5IKO}.
FT   HELIX       498    508       {ECO:0000244|PDB:5IKO}.
FT   HELIX       511    513       {ECO:0000244|PDB:5IKO}.
FT   HELIX       516    526       {ECO:0000244|PDB:5IKO}.
FT   HELIX       529    554       {ECO:0000244|PDB:5IKO}.
FT   STRAND      562    569       {ECO:0000244|PDB:5IKO}.
FT   TURN        573    576       {ECO:0000244|PDB:5IKO}.
FT   HELIX       577    593       {ECO:0000244|PDB:5IKO}.
FT   STRAND      602    607       {ECO:0000244|PDB:5IKO}.
FT   HELIX       615    632       {ECO:0000244|PDB:5IKO}.
FT   TURN        635    637       {ECO:0000244|PDB:5IKO}.
FT   HELIX       638    640       {ECO:0000244|PDB:5IKO}.
FT   STRAND      641    648       {ECO:0000244|PDB:5IKO}.
FT   HELIX       651    657       {ECO:0000244|PDB:5IKO}.
FT   HELIX       658    660       {ECO:0000244|PDB:5IKP}.
FT   STRAND      662    666       {ECO:0000244|PDB:5IKO}.
FT   TURN        670    672       {ECO:0000244|PDB:5IKP}.
FT   HELIX       678    684       {ECO:0000244|PDB:5IKO}.
FT   STRAND      688    691       {ECO:0000244|PDB:5IKO}.
FT   HELIX       696    704       {ECO:0000244|PDB:5IKO}.
FT   HELIX       706    708       {ECO:0000244|PDB:5IKO}.
FT   STRAND      709    711       {ECO:0000244|PDB:5IKO}.
FT   HELIX       716    725       {ECO:0000244|PDB:5IKO}.
FT   HELIX       730    734       {ECO:0000244|PDB:5IKO}.
FT   HELIX       737    748       {ECO:0000244|PDB:5IKO}.
FT   TURN        749    751       {ECO:0000244|PDB:5IKO}.
FT   STRAND      753    755       {ECO:0000244|PDB:5IKP}.
FT   TURN        756    759       {ECO:0000244|PDB:5IKO}.
FT   HELIX       760    768       {ECO:0000244|PDB:5IKO}.
FT   HELIX       774    792       {ECO:0000244|PDB:5IKO}.
FT   HELIX       795    807       {ECO:0000244|PDB:5IKO}.
FT   HELIX       810    812       {ECO:0000244|PDB:5IKO}.
FT   HELIX       814    824       {ECO:0000244|PDB:5IKO}.
SQ   SEQUENCE   843 AA;  96696 MW;  810BFAD3002CACB0 CRC64;
     MAKPLTDSEK RKQISVRGLA GLGDVAEVRK SFNRHLHFTL VKDRNVATPR DYFFALAHTV
     RDHLVGRWIR TQQHYYERDP KRIYYLSLEF YMGRTLQNTM VNLGLQNACD EAIYQLGLDL
     EELEEIEEDA GLGNGGLGRL AACFLDSMAT LGLAAYGYGI RYEFGIFNQK IVNGWQVEEA
     DDWLRYGNPW EKARPEYMLP VHFYGRVEHT PDGVKWLDTQ VVLAMPYDTP VPGYKNNTVN
     TMRLWSAKAP NDFKLQDFNV GDYIEAVLDR NLAENISRVL YPNDNFFEGK ELRLKQEYFV
     VAATLQDIIR RFKSSKFGCR DPVRTCFETF PDKVAIQLND THPALSIPEL MRILVDVEKV
     DWDKAWEITK KTCAYTNHTV LPEALERWPV SMFEKLLPRH LEIIYAINQR HLDHVAALFP
     GDVDRLRRMS VIEEGDCKRI NMAHLCVIGS HAVNGVARIH SEIVKQSVFK DFYELEPEKF
     QNKTNGITPR RWLLLCNPGL ADTIVEKIGE EFLTDLSQLK KLLPLVSDEV FIRDVAKVKQ
     ENKLKFSAFL EKEYKVKINP SSMFDVHVKR IHEYKRQLLN CLHVVTLYNR IKRDPAKAFV
     PRTVMIGGKA APGYHMAKLI IKLVTSIGDV VNHDPVVGDR LKVIFLENYR VSLAEKVIPA
     ADLSQQISTA GTEASGTGNM KFMLNGALTI GTMDGANVEM AEEAGAENLF IFGLRVEDVE
     ALDRKGYNAR EYYDHLPELK QAVDQISSGF FSPKEPDCFK DIVNMLMHHD RFKVFADYEA
     YMQCQAQVDQ LYRNPKEWTK KVIRNIACSG KFSSDRTITE YAREIWGVEP SDLQIPPPNI
     PRD
//
